The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of IBI110 (anti-LAG-3 antibody) plus sintilimab (anti-PD-1 antibody) in patients with advanced alveolar soft part sarcoma: Results from a phase II study.
 
Jiayong Liu
No Relationships to Disclose
 
Zhichao Tan
No Relationships to Disclose
 
Zhengfu Fan
No Relationships to Disclose
 
Chujie Bai
No Relationships to Disclose
 
Ruifeng Xue
No Relationships to Disclose
 
Shu Li
No Relationships to Disclose
 
Tian Gao
No Relationships to Disclose
 
Lu Zhang
No Relationships to Disclose
 
Xinyu Wang
No Relationships to Disclose